Who is sponsoring NCT07238166?

NCT07238166 is sponsored by Assiut University.

What drugs are being tested in NCT07238166?

Interventions in NCT07238166: surgical resection and histopathological examination.

What condition does NCT07238166 study?

NCT07238166 studies Intussusception (IS).

Is NCT07238166 still recruiting?

NCT07238166 is currently not yet recruiting. Last updated 20 November 2025.

Last reviewed 2025-11-20 · How we verify

NCT07238166

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Benign Versus Malignant Causes of Intussuception in Adults

Not yet recruiting NA Last updated 20 November 2025

What this trial tests

NA trial testing surgical resection and histopathological examination in Intussusception (IS) in 35 participants. Not yet recruiting.

Timeline

1 December 2025

Primary endpoint
1 December 2027

1 December 2027

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	35
Start date	1 December 2025
Primary completion	1 December 2027
Estimated completion	1 December 2027
Sites	1 location across Egypt

Drugs / interventions tested

surgical resection and histopathological examination

Conditions studied

Intussusception (IS) — all drugs for Intussusception (IS) →

Sponsor

Assiut University

Who can join

19 and older, any sex, with Intussusception (IS). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate adult intussecption : * Prevalence of benign vs malignant causes. * Distribution by anatomical type. * Clinical presentation patterns. * Diagnostic accuracy of imaging. * Surgical approach and outcomes. * Length of hospital stay, complications, recurrence

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07238166 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 20 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07238166.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing